Smithfield’s “We Speak Pork” Campaign Features Pork So Good It Speaks for Itself

(NASDAQ:SFD), SMITHFIELD, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) — Smithfield(R) has launched a new national advertising campaign, “We Speak Pork,” showcasing pork so good it speaks for itself. The video campaign features Emmy Award-winning writer, actor and comedian Ben Schwartz as the voice of Smithfield's portfolio of products, including bacon, Prime Fresh lunch meat, smoked […]

Smithfield’s “We Speak Pork” Campaign Features Pork So Good It Speaks for Itself

Smithfield's “We Speak Pork” Campaign Features Pork So Good It Speaks for Itself Creative platform designed to drive awareness among Gen Z and Millennials, expand Smithfield's leadership in packaged meats segment GlobeNewswire August 05, 2025 SMITHFIELD, Va., Aug. 05, 2025 (GLOBE NEWSWIRE) — Smithfield(R) has launched a new national advertising campaign, “We Speak Pork,” showcasing

V.F. Corporation Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – VFC

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of V.F. Corporation ("V.F. Corporation") (NYSE:VFC) concerning possible violations of federal securities laws. On May 21, 2025, VFC issued a press release announcing that the company’s fourth quarter fiscal 2025 results failed to

Bruker Corporation (BRKR) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bruker Corporation ("Bruker Corporation") (NASDAQ:BRKR) concerning possible violations of federal securities laws. On July 21, 2025, Bruker announced disappointing preliminary results for the second quarter, ended June 30, 2025. The Company disclosed

Pyxus International Named as a Supplier Engagement Leader by CDP

Recognized for collaborative efforts with suppliers, particularly its global farmer base — Earns CDP Supplier Engagement 'A' ranking for second consecutive year — Pyxus International, Inc. (OTCID: PYYX), a global value-added agricultural company, is pleased to announce it has been named a Supplier Engagement Leader by environmental nonprofit CDP. Pyxus ranked amongst the top tier

INFA STOCK ALERT: Levi & Korsinsky Notifies Informatica Inc. Investors of an Ongoing Investigation

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Informatica Inc. ("Informatica Inc.") (NYSE:INFA) concerning possible violations of federal securities laws. On February 13, 2025, Informatica issued a press release announcing its fourth quarter 2024 financial results, missing revenue forecasts and

Lost Money on Cytokinetics, Incorporated (CYTK)? You May Have Been Affected by Fraud – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has

Lost Money on Teva Pharmaceutical Industries Limited(TEVA)? You May Have Been Affected by Fraud – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Teva Pharmaceutical Industries Limited ("Teva Pharmaceutical Industries Limited") (NYSE:TEVA) concerning possible violations of federal securities laws. On July 31, 2025, Teva published a press release reporting the Company’s second quarter 2025 financial

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

(NASDAQ:QNTM),(CNSX:QNTM.CN),(Boerse Frankfurt – Freiverkehr:0K91),(CNSX:QNTM), TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company“), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, Huge Biopharma Australia Pty Ltd., that it has received the clinical

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS)

Quantum Biopharma Announces Positive Results of the Clinical Study Report (CSR) for the Phase 1 Multiple Ascending Dose (MAD) Clinical Trial of Experimental Multiple Sclerosis Drug Lucid-21-302 (Lucid-MS) GlobeNewswire August 05, 2025 TORONTO, Aug. 05, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company“), a biopharmaceutical

Scroll to Top